Cabometyx is under clinical development by Exelixis and currently in Phase II for Salivary Gland Cancer. According to GlobalData, Phase II drugs for Salivary Gland Cancer have a 14% phase transition ...
USA Medical Dr David Brownstein has tested, over the years about 8,000 patients for iodine levels and found 97% of them deficient in iodine. Other medics find the same results themselves.